How much does it cost to import Pertuzumab?

Pertuzumab is a cancer drug used to treat adults with "HER2-positive" breast cancer (a protein called HER2 found on cancer cells) that contains the active substance pertuzumab. Pertuzumab is used to treat metastatic breast cancer (cancer that has spread to other parts of the body) that has not been treated with chemotherapy or drugs that target HER2, or breast cancer that has come back locally after treatment and cannot be removed with surgery.

In these circumstances, Pertuzumab is used with trastuzumab and docetaxel (other cancer drugs); before patients undergo surgery, pertuzumab can be used in combination with trastuzumab and chemotherapy to treat locally advanced, inflammatory, or early-stage breast cancer with a high risk of recurrence; after patients have surgery, pertuzumab can be used in combination with trastuzumab and chemotherapy to treat early-stage breast cancer with a high risk of recurrence. The common dosage forms of Pertuzumab are single-dose vials of 420mg/14mL (30mg/mL), and each box contains approximately one 420mg/14mL dose of Pertuzumab.

Pertuzumab is a strictly controlled drug. The original drug has been marketed in China and has entered the ranks of medical insurance, but it is only reimbursed for patients who meet the indications. The price of each box may be more than more than 5,000 yuan, and the price of the Hong Kong version may be more than 20,000 yuan (the price may fluctuate due to exchange rates). The price of each box of the European version of Pertuzumab's original drug marketed overseas may be more than 10,000 yuan, and the price of each box of the Turkish version may be more than 6,000 yuan (the price may fluctuate due to exchange rates). The ingredients of the domestic and foreign original drugs are basically the same, and there are currently no generic versions of Pertuzumab on the market.